Despite Ozempic and Mounjaro not being approved for weight loss, news of people rapidly losing weight spread, and off-label uses became more popular
If you are not sure where to begin, the Supplement Quiz is a simple way to get personalized guidance
Early non-response is not failure
Any changes in MS symptoms during semaglutide therapy should prompt standard neurological evaluation to distinguish medication effects from disease activity
Additionally, GLP-1 therapies are gaining recognition as a novel approach to Alzheimers disease due to their anti-inflammatory and neuroprotective characteristics
Wang N, Gao J, Jia M, Ma X, Lei Z, Da F, Yan F, Zhang H, Zhou Y, Li M